OJJAARA
Live / Registered — Registered (as of 12 Mar 2024)
What this means for you
Registered since 12 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90058874
- Registration number
- 7327771
- Mark type
- Stylized text
- Filed
- 17 Jul 2020
- Published for opposition
- 08 Jun 2021
- Registered
- 12 Mar 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and drugs for the treatment of cancer, namely, myelofibrosis (mf); pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; biological and chemical preparations for the treatment of cancer; pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders
Owner
- GLAXOSMITHKLINE LLC, WILMINGTON, DE, US
- GLAXOSMITHKLINE LLC, WILMINGTON, DE, US
- Sierra Oncology, Inc., Wilmington, DE, US
- Sierra Oncology, Inc., Vancouver, B.C., DE, US
Prosecution history
- 12 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 07 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jan 2024 — USE AMENDMENT FILED
- 06 Feb 2024 — SOU EXTENSION 5 GRANTED
- 22 Jan 2024 — SOU EXTENSION 5 FILED
- 06 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 22 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 03 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2023 — SOU EXTENSION 4 GRANTED
- 01 Aug 2023 — SOU EXTENSION 4 FILED